Australia markets closed

Genovate Biotechnology Co., Ltd. (4130.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
22.95+0.20 (+0.88%)
At close: 01:30PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
27,299
29,334
-12,323
372
38,731
-
Depreciation & amortisation
36,956
36,548
36,088
35,816
35,209
-
Stock-based compensation
-
0
11,700
0
-
-
Change in working capital
21,359
17,823
-33,024
-54,802
16,153
-
Inventory
146
6,219
-5,918
-304
-4,015
-
Other working capital
62,717
51,439
-22,504
-35,393
59,920
-
Other non-cash items
-5,665
-4,740
-2,443
-1,353
-1,913
-
Net cash provided by operating activities
91,623
84,782
1,510
-17,259
87,079
-
Cash flows from investing activities
Investments in property, plant and equipment
-28,906
-33,343
-24,014
-18,134
-27,159
-
Acquisitions, net
-
-
-
-
-
0
Purchases of investments
-47,207
-41,145
-104,900
-25,000
-65,000
-
Sales/maturities of investments
14,973
0
121,933
82,122
74,456
-
Other investing activities
-3,081
-4,195
1,234
-2,092
2,603
-
Net cash used for investing activities
-61,146
-78,683
-5,747
36,896
-15,100
-
Net change in cash
10,115
-14,133
-4,276
-24,772
22,544
-
Cash at beginning of period
182,596
194,165
198,441
223,213
200,669
-
Cash at end of period
192,711
180,032
194,165
198,441
223,213
-
Free cash flow
Operating cash flow
91,623
84,782
1,510
-17,259
87,079
-
Capital expenditure
-28,906
-33,343
-24,014
-18,134
-27,159
-
Free cash flow
62,717
51,439
-22,504
-35,393
59,920
-